Aligning sample size calculations with estimands in clinical trials with time-to-event outcomes

被引:0
|
作者
Fang, Yixin [1 ]
Jin, Man [1 ]
Wu, Chengqing [2 ]
机构
[1] Fang 1 North Waukegan Rd, N Chicago, IL 60064 USA
[2] 55,Challenger Rd STE 501, Ridgefield Pk, NJ 07660 USA
关键词
AND PHRASES; Clinical trials; Estimand; current events; Sample size; Time-to-event;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ICH E9(R1) guidance recommended a framework to align planning, design, conduct, analysis, and interpretation of any clincial trial with its objective and estimand. How to handle intercurrent events (ICEs) is one of the five attributes of an estimand and sample size calculation is a key step in the trial planning and design. Therefore, sample size calcula-tion should be aligned with the estimand and, in particular, with how the ICEs are handled. ICH E9(R1) summarized five strategies for handling ICEs, and five approaches have been proposed in the literature for sample size calculation when planning trials with quantitative and binary outcomes. In this paper, we discuss how to apply the five strategies to deal with ICEs in clinical trials with time-to-event outcomes and propose five approaches for sample size calculation that are aligned with the five strategies, respectively. AMS 2000 SUBJECT CLASSIFICATIONS: Primary 62N03, 62G10; secondary 62G99.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [41] A menu-driven facility for sample-size calculation in multiarm, multistage randomized controlled trials with time-to-event outcomes: Update
    Bratton, Daniel J.
    Choodari-Oskooei, Babak
    Royston, Patrick
    STATA JOURNAL, 2015, 15 (02): : 350 - 368
  • [42] Power and sample-size analysis for the Royston Parmar combined test in clinical trials with a time-to-event outcome: Correction and program update
    Royston, Patrick
    STATA JOURNAL, 2018, 18 (04): : 995 - 996
  • [43] Sample size determination in superiority or non-inferiority clinical trials with time-to-event data under exponential, Weibull and Gompertz distributions
    Han, Dong
    Hou, Yawen
    Ou, Chunquan
    Chen, Zheng
    COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2023, 52 (04) : 1212 - 1224
  • [44] Milestone prediction for time-to-event endpoint monitoring in clinical trials
    Ou, Fang-Shu
    Heller, Martin
    Shi, Qian
    PHARMACEUTICAL STATISTICS, 2019, 18 (04) : 433 - 446
  • [45] Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials
    Hamasaki, Toshimitsu
    Asakura, Koko
    Sugimoto, Tomoyuki
    Evans, Scott R.
    Yamamoto, Haruko
    Hsiao, Chin-Fu
    TRIALS, 2017, 18
  • [46] Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes
    Riley, Richard D.
    Snell, Kym I. E.
    Ensor, Joie
    Burke, Danielle L.
    Harrell, Frank E., Jr.
    Moons, Karel G. M.
    Collins, Gary S.
    STATISTICS IN MEDICINE, 2019, 38 (07) : 1276 - 1296
  • [47] Projection of power and events in clinical trials with a time-to-event outcome
    Royston, Patrick
    Barthel, Friederike M-S
    STATA JOURNAL, 2010, 10 (03): : 386 - 394
  • [48] Predicting study duration in clinical trials with a time-to-event endpoint
    Machida, Ryunosuke
    Fujii, Yosuke
    Sozu, Takashi
    STATISTICS IN MEDICINE, 2021, 40 (10) : 2413 - 2421
  • [49] The importance of accurate sample size calculations in clinical trials
    Moran, Jose M.
    Aliaga, Ignacio
    Pedrera-Zamorano, Juan D.
    ARCHIVES OF OSTEOPOROSIS, 2017, 12 (01)
  • [50] The importance of accurate sample size calculations in clinical trials
    Jose M. Moran
    Ignacio Aliaga
    Juan D. Pedrera-Zamorano
    Archives of Osteoporosis, 2017, 12